Neurofibromatosis 1: Clinical manifestations and diagnostic criteria

Journal of Child Neurology

Volumn 17, Issue 8, 2002, Pages 548-554

  Friedman, J M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; BONE LESION; CAFE AU LAIT SPOT; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLIOMA; HAMARTOMA; HUMAN; INCIDENCE; LEARNING DISORDER; LENTIGO; MALE; NERVE SHEATH TUMOR; NEUROFIBROMA; NEUROFIBROMATOSIS; PATHOGENESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW;

EID: 0036700962     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307380201700802     Document Type: Review

References (70)

1. Konrad K, Wolff K, Hönigsmann H: The giant melanosome: A model of deranged melanosome morphogenesis. J Ultrastruct Res 1974;48:102-123.
2. Bhawan J, Purtilo D, Riordan J, et al: Giant and "granular melanosomes" in LEOPARD syndrome: An ultrastructural study. J Cutan Pathol 1976;3:207-216.
3. Martuza R, Phillippe I, Fitzpatrick T, et al: Melanin macroglobules as a cellular marker of neurofibromatosis: A quantitative study. J Invest Dermatol 1985;85:347-350.
4. Lott I, Richardson E: Neuropathological findings and the biology of neurofibromatosis. Adv Neurol 1981;29:23-32.
5. Korf B: Plexiform neurofibromas. Am J Med Genet 1999;89:31-37.
6. Waggoner D, Towbin J, Gottesman G, Gutmann D: Clinic-based study of plexiform neurofibromas in neurofibromatosis 1. Am J Med Genet 2000;92:132-135.
7. Woodruff J: Pathology of tumors of the peripheral nerve sheath in type 1 neurofibroimatosis. Am J Med Genet 1999;89:23-30.
8. Lubs M-L, Bauer M, Formas M, Djokic B: Lisch nodules in neurofibromatosis type 1. N Engl J Med 1991;324:1264-1266.
9. Lewis R, Riccardi V: Von Recklinghausen neurofibromatosis: Incidence of iris hamartomata. Ophthalmology 1981;88:348-354.
10. Riccardi V: Von Recklinghausen neurofibromatosis. N Engl J Med 1981;305:1617-1627.
11. Listenick R, Gutmann DH: Tumors of the optic pathway, in Friedman JM, Gutmann DH, MacCollin M, Riccardi VM (eds): Neurofibromatosis: Phenotype, Natural History, and Pathogenesis. 3rd ed. Baltimore, Johns Hopkins University Press, 1999,203-230.
12. Listenick R, Charrow J, Gutmann DH: Intracranial gliomas in neurofibromatosis type 1. Am J Med Genet 1999;89:38-44.
13. Von Recklinghausen F: Über die Multiplen Fibrome der Haut und Ihre Beziehungen zu Multiplen Neuromen. Berlin, August Hirschwald, 1882.
14. National Institutes of Health Consensus Development Conference: Neurofibromatosis: Conference statement. Arch Neurol 1988;45:575-578.
15. Wallace M, Marchuk D, Andersen LB, et al: Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients. Science 1990;249:181-186.
16. Viskochil D, Buchberg A, Xu G, et al: Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 1990;62:187-192.
17. Cawthon R, Weiss R, Xu G, et al: A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 1990;62:193-201.
18. Gutmann D, Aylsworth A, Carey J, et al: The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997;278:51-57.
19. DeBella K, Szudek J, Friedman JM: Use of the National Institutes of Health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics 2000; 105:608-614.
20. Goldberg Y, Dibbern K, Klein J, et al: Neurofibromatosis type 1 An update and review for the primary pediatrician. Clin Pediatr (Phila) 1996;35:545-561.
21. Friedman J, Birch P: Type 1 neurofibromatosis: A descriptive analysis of the disorder in 1,728 patients. Am J Med Genet 1997;70:138-143.
22. Curless R, Siatkowski M, Glaser J, Shatz N: MRI diagnosis of NF1 in children without café-au-lait skin lesions. Pediatr Neurol 1998;18:269-271.
23. Van Es S, North K, McHugh K, De Silva M: MRI findings in children with neurofibromatosis type 1: A prospective study. Pediatr Radiol 1996;26:478-487.
24. DiMario F, Ramsby G, Greenstein R, et al: Neurofibromatosis type 1: Magnetic resonance imaging findings. J Child Neurol 1993;18:32-39.
25. Balestri P, Calistri L, Vivarelli R, et al: Central nervous system imaging in reevaluation of patients with neurofibromatosis type 1. Childs Nerv Syst 1993;9:448-451.
26. DeBella Y, Poskitt K, Szudek J, Friedman JM: Use of unidentified bright objects on MRI for diagnosis of neurofibromatosis 1 in children. Neurology 2000;54:1646-1651.
27. Bolande R: The neurocristopathies: A unifying concept of disease arising in neural crest development. Hum Pathol 1974;5:409-429.
28. Bolande R: Neurofibromatosis-The quintessential neurocristopathy: Pathogenic concepts and relationships. Adv Neurol 1981;29:67-75.
29. Stocker K, Baizer L, Coston T, et al: Regulated expression of neurofibromin in migrating neural crest cells of avian embryos. J Neurobiol 1995;27:535-552.
30. Hamilton SJ, Friedman JM: Insights into the pathogenesis of neurofibromatosis 1 vasculopathy. Clin Genet 2000;58:341-,344.
31. King A, Debaun M, Riccardi V, Gutmann D: Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Med Genet 2000;93:388-392.
32. Gutmann D, Gurney J: Other malignancies, in Friedman JM, Gutmann DH, MacCollin M, Riccardi VM (eds): Neurofibromatosis: Phenotype, Natural History, and Pathogenesis, 3rd ed. Baltimore, Johns Hopkins University Press, 1999, 231-249.
33. Korf B: Neurofibromas and malignant tumors of the peripheral nerve sheath, in Friedman J, Gutmann D, MacCollin M, Riccardi V (eds): Neurofibromatosis: Phenotype, Natural History, and Pathogenesis, 3rd ed. Baltimore, Johns Hopkins University Press, 1999, 142-161.
34. Kluwe L, Hagel C, Tatagiba M, et al: Loss of NF1 alleles distinguish sporadic from NFl-associated pilocytic astrocytomas. J Neuropathol Exp Neurol 2001;60:917-920.
35. Gutmann DH, Donahoe J, Brown T, et al: Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas. Neuropathol Appl Neurobiol 2000;26: 361-367.
36. Szudek J, Birch P, Friedman JM: Growth in North American white children with neurofibromatosis 1 (NF1). J Med Genet 2000;37:933-938.
37. Gregory P, Gutmann D, Mitchell A, et al: Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules. Somat Cell Mol Genet 1993; 19:265-274.
38. Bollag G, McCormick F Clark R: Characterization of full-length neurofibromin: Tubulin inhibits Ras GAP activity EMBO J 1993;12:1923-1927.
39. Guo H, Tong J, Hannan F, et al: A neurofibromatosis-1-regulated pathway is required for learning in Drosophila. Nature 2000;403:895-898.
40. Ingrain DA, Yang FC, Travers JB, et al: Genetic and biochemical evidence that haploinsufficiency of the NF1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo. J Exp Med 2000;191:181-188.
41. Gutmann DH, Loehr A, Zhang Y, et al: Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation. Oncogene 1999;18:4450-4459.
42. Friedman JM, Riccardi VM: Clinical and epidemiological features, in Friedman JM, Gutmann DH, MacCollin M, Riccardi VM (eds): Neurofibromatosis: Phenotype, Natural History, and Pathogenesis, 3rd ed. Baltimore, Johns Hopkins University Press, 1999,29-86.
43. Friedman JM, Birch P: An association between optic glioma and other tumours of the central nervous system in neurofibromatosis type 1. Neuropediatrics 1997;28:131-132.
44. Szudek J, Evans D, Friedman J: Logistic regresssive models of neurofibromatosis 1 (NF1 clinical features. Submitted.
45. Szudek J, Birch P, Riccardi VM, et al: Associations of clinical features in neurofibromatosis 1 (NF1). Genet Epidemiol 2000;19:429-439.
46. Upadhaya M, Shen M, Chenyson A, et al: Analysis of mutations at the neurofibromatosis (NF1) locus. Hum Mot Genet 1992;1:735-740.
47. Allanson J, Upadhaya M, Watson G, et al: Watson syndrome: Is it a subtype of type 1 neurofibromatosis? J Med Genet 1991;28:752-756.
48. Abeliovich D, Gelman-Kohan Z, Silverstein S, et al: Familial cafe au lait spots: A variant of neurofibromatosis type 1. J Med Genet 1995;32:985-986.
49. Ars E, Kruyer H, Gaona A, et al: A clinical variant of neurofibromatosis type 1: Familial spinal neurofibromatosis with a frameshift mutation in the NF1 gene. Am J Hum Genet 1998;62:834-841.
50. Pulst SM, Riccardi VM, Fain P, Korenberg JR: Familial spinal neurofibromatosis: Clinical and DNA linkage analysis. Neurology 1991;41:1923-1927.
51. Poyhonen M, Leisti E-L, Kytölä S, Leisti J: Hereditary spinal neurofibromatosis: A rare form of NF1? J Med Genet 1997;34:184-187.
52. Poyhonen M, Niemela S, Herva R: Risk of malignancy and death in neurofibromatosis. Arch Pathol Lab Med 1997; 121:139-143.
53. Meis J, Enzinger F, Martz K, Neal J: Malignant peripheral nerve sheath turnors (malignant schwannomas) in children. Am J Surg Pathol 1992;16:694-707.
54. Shearer P Parham D, Kovnar E, et al: Neurofibromatosis type I and malignancy: Review of 32 pediatric cases treated at a single institution. Med Pediatr Oncol 1994;22:78-83.
55. Colley A, Donnai D, Evans DG: Neurofibromatosis/Noonan phenotype: A variable feature of type 1 neurofibromatosis. Clin Genet 1996;49:59-64.
56. Kayes L, Burke W, Riccardi V, et al: Deletions spanning the neurofibromatosis 1 gene: Identification and phenotype of five patients. Am J Hum Genet 1994;54:424-436.
57. Stern H, Saal H, Lee J, et al: Clinical variability of type 1 neurofibromatosis: Is there a neurofibromatosis-Noonan syndrome? J Med Genet 1992;29:184-187.
58. Tassabehji M, Strachan T, Sharland M, et al: Tandem duplication within a neurofibromatosis type I (NFI) gene exon in a family with features of Watson syndrome and Noonan syndrome. Am J Hum Genet 1993;53:90-95.
59. van Asperen CJ, Overweg-Plandsoen WC, Cnossen MH, et al: Familial neurofibromatosis type 1 associated with an overgrowth syndrome resembling Weaver syndrome. J Med Genet 1998;35:323-327.
60. Easton D, Ponder M, Huson S, Ponder B: An analysis of variation in expression of neurofibromatosis (NF) type I (NF1): Evidence for modifying genes. Am J Hum Genet 1993;53:305-313.
61. Szudek J, Joe H, Friedman JM: Analysis of intrafamilial phenotypic variation in neurofibromatosis 1 (NF1). Genet Epidemiol (in press).
62. Wolkenstein P, Durand-Zaleski I, Moreno J, et al: Cost evaluation of the medical management of neurofibromatosis 1: A prospective study on 201 patients. Br J Dermatol 2000; 142:1166-1170.
63. Rasmussen S, Yang Q, Friedman J: Mortality in neurofibromatosis 1: An analysis using U.S. death certificates. Am J Hum Genet 2001;68:1110-1118.
64. Evans DG, Baser M, McGaughran J, et al: Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Hum Genet 2001;69:307.
65. Gutmann D: Abnormalities of the nervous system, in Friedman JM, Gutmann DH, MacCollin M, Riccardi VM (eds): Neurofibromatosis: Phenotype, Natural History, and Pathogenesis, 3rd ed. Baltimore, Johns Hopkins University Press, 1999, 190-202.
66. Sørensen S, Mulvihill J, Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis: Survival and malignant neoplasms. N Engl J Med 1986;314:1010-1015.
67. Sobata E, Ohkuma H, Suzuki S: Cerebrovascular disorders associated with von Recklinghausen's neurofibromatosis: A case report. Neurosurgery 1988;22:544-549.
68. Zochodne D: Von Recklinghausen's vasculopathy. Am J Med Sci 1984;287:64-65.
69. Brooks B, el Garnmal T, Adams R, et al: MR imaging of moyamoya in neurofibromatosis. AJNR Am J Neuroradiol 1987;8:178-179.
70. Schievink W, Michels V, Piepgras D: Neurovascular manifestations of heritable connective tissue disorders. A review. Stroke 1994;25: 889-903.